Skip to content
★ Sign in to follow
TS

Tord Staffan Håkan Skogvall

Executive
Chief Executive Officer
PharmaLundensis ABPhal
Insider activity · 24 months6 buys3 salesCumulative net flow
Total declarations
62
Companies
2
▲ Purchases (47 ops.)
€167k
▼ Sales (9 ops.)
€49k

Latest filing published 05 Jul 2026 for PharmaLundensis AB, €5,325.

Filing timeline

BuySale
Tord Staffan Håkan Skogvall

Insider track record

Disclosed buys
47
Disclosed sells
9
Signal history

Closed purchases

Market purchases
47

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tord Staffan Håkan Skogvall: trading record in brief

Tord Staffan Håkan Skogvall is a declared insider at 2 companies (chief executive); the most frequent names are PharmaLundensis AB and Phal. In total, 62 filings cover trades dated from 26 May 2017 to 1 July 2026.

On the open market, the record shows 47 purchases worth €167k and 9 sales worth €49k. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at no purchases and 3 sales.

In size, the median ticket on the buying side is €1,668. Clusters matter here: 9 out of 44 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 5 July 2026 came the latest disclosure, an open-market sale for €5,325 in PharmaLundensis AB. The last purchase on record was published on 25 September 2025, which is 409 days ago. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Tord Staffan Håkan Skogvall

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations61 total
  • ▼
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    59,492 SEK27FI-SE
    148,138 shares@ SEK 0.40160.30% mcap12.3% of flowAktieISIN SE0027620469FI:csv-99a3c5b806eb35e2fdb4
  • ▼
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    165,386 SEK25FI-SE
    1,181,325 shares@ SEK 0.140.82% mcap34.9% of flowAktieISIN SE0027620469FI:A003Z737-1
  • ●
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    100,000 SEK0FI-SE
    200,000 shares@ SEK 0.5021.6% of flowBTA (betald tecknad aktie)ISIN SE0027620469FI:A003W437-1
  • ▼
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    143,164 SEK25FI-SE
    223,693 shares@ SEK 0.640.71% mcap30.1% of flowAktieISIN SE0003359710FI:A003S799-1
  • ▲
    Verkställande direktör (VD)ExecutivesPhal
    17,543 SEK24FI-SE
    92,333 shares@ SEK 0.1924.7% of flowAktieISIN SE0003359710FI:csv-1df2c3ac5cf89f83df78
    Canonical exit: 23 Dec 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPhal
    13,864 SEK24FI-SE
    63,017 shares@ SEK 0.2219.5% of flowAktieISIN SE0003359710FI:csv-a19f06e3d1615c65dc1c
    Canonical exit: 23 Dec 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPhal
    13,131 SEK24FI-SE
    65,656 shares@ SEK 0.2018.5% of flowAktieISIN SE0003359710FI:csv-3b52a6f4cf7eb4a1b6fc
    Canonical exit: 22 Dec 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    1,986 SEK34FI-SE
    2,337 shares@ SEK 0.850.0099% mcap0.4% of flowAktieISIN SE0003359710FI:A003M487-1
    Canonical exit: 9 Jun 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    3,156 SEK34FI-SE
    3,713 shares@ SEK 0.850.016% mcap0.7% of flowAktieISIN SE0003359710FI:A003M348-1
    Canonical exit: 4 Jun 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPhal
    7,999 SEK35FI-SE
    10,958 shares@ SEK 0.7310.8% of flowAktieISIN SE0003359710FI:csv-8b4a01aada0d9a8c2cc7
    Canonical exit: 17 Apr 2025 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    10,336 SEK37FI-SE
    27,936 shares@ SEK 0.370.4% of flowAktieISIN SE0003359710FI:csv-4a9d6a69b9433a08d0bb
    Canonical exit: 7 Jan 2025 (T+90)
  • ●
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    100,000 SEK0FI-SE
    200,000 shares@ SEK 0.503.9% of flowBTU (betald tecknad unit)ISIN SE0022727244FI:csv-3ab3711fa527de21f44e
  • ▲
    Verkställande direktör (VD)ExecutivesPhal
    19,482 SEK30FI-SE
    45,308 shares@ SEK 0.43100.0% of flowAktieISIN SE0019912783FI:csv-f4ba19d0fe59d39231d7
    Canonical exit: 8 Dec 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    20,700 SEK22FI-SE
    45,000 shares@ SEK 0.460.8% of flowAktieISIN SE0019912783FI:csv-db8e750f369cf8614b99
    Canonical exit: 1 Dec 2024 (T+90)
  • ●
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    180,000 SEK23FI-SE
    200,000 shares@ SEK 0.906.9% of flowAktieISIN SE0019912783FI:csv-44d01570d4a94d0f4466
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    80,750 SEK34FI-SE
    95,000 shares@ SEK 0.853.2% of flowAktieISIN SE0019912783FI:csv-ae237be2169a34891750
    Canonical exit: 16 Jun 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    38,404 SEK34FI-SE
    46,270 shares@ SEK 0.831.5% of flowAktieISIN SE0019912783FI:csv-402bf2e5b5a2665bf589
    Canonical exit: 10 Jun 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    52,791 SEK34FI-SE
    82,486 shares@ SEK 0.642.1% of flowAktieISIN SE0019912783FI:csv-54d8b933bac23e3ac157
    Canonical exit: 6 Jun 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    131,808 SEK35FI-SE
    201,850 shares@ SEK 0.6535.2% of flowAktieISIN SE0019912783FI:csv-2119f24ff9b4f0e7146b
    Canonical exit: 19 May 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    46,724 SEK34FI-SE
    129,790 shares@ SEK 0.361.9% of flowAktieISIN SE0019912783FI:csv-22e999ef196c6d31dd6b
    Canonical exit: 26 Mar 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    84,882 SEK22FI-SE
    273,813 shares@ SEK 0.313.2% of flowAktieISIN SE0019912783FI:csv-fd241f3a1f1d64ed72dd
    Canonical exit: 28 Sept 2023 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    532,172 SEK0FI-SE
    1,064,343 shares@ SEK 0.5021.0% of flowBTU (betald tecknad unit)ISIN SE0019912783FI:csv-3b830e20b2662b218e4d
    Canonical exit: 22 Jun 2023 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    95,872 SEK22FI-SE
    187,984 shares@ SEK 0.513.7% of flowAktieISIN SE0003359710FI:csv-1c08ac2c8b3700b092d8
    Canonical exit: 11 Jun 2023 (T+90)
  • ●
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    0FI-SE
    9,646,290 shares0AktieISIN SE0003359710FI:csv-ab0e532178463d646319
  • ▲
    Verkställande direktör (VD)ExecutivesPharmaLundensis AB
    38,425 SEK22FI-SE
    47,147 shares@ SEK 0.8151.6% of flowAktieISIN SE0003359710FI:csv-f8d13e324f9899a3082b
    Canonical exit: 16 Jan 2023 (T+90)

25 of 61 declarations